Literature DB >> 28678484

Protein-Ligand Empirical Interaction Components for Virtual Screening.

Yuna Yan1,2,3, Weijun Wang1,2,3, Zhaoxi Sun1,2,3, John Z H Zhang1,2,3, Changge Ji1,2,3.   

Abstract

A major shortcoming of empirical scoring functions is that they often fail to predict binding affinity properly. Removing false positives of docking results is one of the most challenging works in structure-based virtual screening. Postdocking filters, making use of all kinds of experimental structure and activity information, may help in solving the issue. We describe a new method based on detailed protein-ligand interaction decomposition and machine learning. Protein-ligand empirical interaction components (PLEIC) are used as descriptors for support vector machine learning to develop a classification model (PLEIC-SVM) to discriminate false positives from true positives. Experimentally derived activity information is used for model training. An extensive benchmark study on 36 diverse data sets from the DUD-E database has been performed to evaluate the performance of the new method. The results show that the new method performs much better than standard empirical scoring functions in structure-based virtual screening. The trained PLEIC-SVM model is able to capture important interaction patterns between ligand and protein residues for one specific target, which is helpful in discarding false positives in postdocking filtering.

Mesh:

Substances:

Year:  2017        PMID: 28678484     DOI: 10.1021/acs.jcim.7b00017

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  12 in total

Review 1.  Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.

Authors:  Vertika Gautam; Anand Gaurav; Neeraj Masand; Vannajan Sanghiran Lee; Vaishali M Patil
Journal:  Mol Divers       Date:  2022-07-11       Impact factor: 3.364

2.  SAMPL7 TrimerTrip host-guest binding poses and binding affinities from spherical-coordinates-biased simulations.

Authors:  Zhaoxi Sun
Journal:  J Comput Aided Mol Des       Date:  2020-08-10       Impact factor: 3.686

3.  Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction.

Authors:  Beihong Ji; Xibing He; Jingchen Zhai; Yuzhao Zhang; Viet Hoang Man; Junmei Wang
Journal:  Brief Bioinform       Date:  2021-09-02       Impact factor: 11.622

4.  Hidden bias in the DUD-E dataset leads to misleading performance of deep learning in structure-based virtual screening.

Authors:  Lieyang Chen; Anthony Cruz; Steven Ramsey; Callum J Dickson; Jose S Duca; Viktor Hornak; David R Koes; Tom Kurtzman
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

5.  New machine learning and physics-based scoring functions for drug discovery.

Authors:  Isabella A Guedes; André M S Barreto; Diogo Marinho; Eduardo Krempser; Mélaine A Kuenemann; Olivier Sperandio; Laurent E Dardenne; Maria A Miteva
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

6.  Rational Computational Design of Fourth-Generation EGFR Inhibitors to Combat Drug-Resistant Non-Small Cell Lung Cancer.

Authors:  Hwangseo Park; Hoi-Yun Jung; Kewon Kim; Myojeong Kim; Sungwoo Hong
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

7.  Collaborative Approach between Explainable Artificial Intelligence and Simplified Chemical Interactions to Explore Active Ligands for Cyclin-Dependent Kinase 2.

Authors:  Tomomi Shimazaki; Masanori Tachikawa
Journal:  ACS Omega       Date:  2022-03-18

Review 8.  Structure-based protein-ligand interaction fingerprints for binding affinity prediction.

Authors:  Debby D Wang; Moon-Tong Chan; Hong Yan
Journal:  Comput Struct Biotechnol J       Date:  2021-11-25       Impact factor: 7.271

9.  Improving the Virtual Screening Ability of Target-Specific Scoring Functions Using Deep Learning Methods.

Authors:  Dingyan Wang; Chen Cui; Xiaoyu Ding; Zhaoping Xiong; Mingyue Zheng; Xiaomin Luo; Hualiang Jiang; Kaixian Chen
Journal:  Front Pharmacol       Date:  2019-08-22       Impact factor: 5.810

10.  Structure-Based Virtual Screening and De Novo Design of PIM1 Inhibitors with Anticancer Activity from Natural Products.

Authors:  Hwangseo Park; Jinwon Jeon; Kewon Kim; Soyeon Choi; Sungwoo Hong
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.